Browse the evidence

Activation of the AMPKα2 isoform inhibits skeletal muscle hypertrophy and promotes protein degradation (atrophy) by suppressing mTORC1 signaling and activating FoxO-mediated ubiquitin-proteasome pathways.

If your goal is maximum muscle size, be aware that high-intensity endurance exercise or conditions that heavily activate AMPK (like severe caloric restriction) may blunt muscle growth. This is because the body prioritizes energy production over building new tissue. To maximize hypertrophy, focus on resistance training protocols that minimize excessive AMPK activation (e.g., avoid excessive cardio immediately before lifting).

Disruption of arcuate nucleus (ARC) neuronal regulation of energy balance and glucose homeostasis is a primary driver of obesity and type 2 diabetes mellitus.

Understanding that obesity is driven by biological signals in the brain (specifically the arcuate nucleus) helps explain why willpower alone is often insufficient for weight loss. This biological perspective supports the need for medical or behavioral interventions that address these underlying regulatory mechanisms rather than blaming individual choice.

AgRP neurons promote feeding and induce acute insulin resistance to prioritize glucose availability for the brain during hunger.

During periods of fasting or caloric restriction, the body biologically reduces insulin sensitivity in peripheral tissues to ensure the brain receives enough glucose. This is a survival mechanism driven by AgRP neurons, not a defect.

Leptin signaling in the arcuate nucleus is critical for regulating body weight, with its effects mediated primarily through AgRP and POMC neurons.

Leptin signals fat stores to the brain to regulate hunger. In obesity, this signaling may be disrupted (leptin resistance), making weight management harder. Understanding this biological signal helps explain why simple calorie restriction often fails long-term.

Beige adipocytes utilize a UCP1-independent thermogenic mechanism driven by ATP-dependent Ca2+ cycling via SERCA2b and RyR2, which contributes to systemic energy expenditure and glucose homeostasis.

If you lack functional brown fat (common in obesity or aging), you may still possess beige fat capable of generating heat through alternative calcium-based mechanisms. Strategies that induce 'beiging' (like cold exposure or exercise) may still improve metabolic health even if they don't rely on UCP1.

Creatine substrate cycling serves as a UCP1-independent thermogenic pathway in beige adipocytes, contributing to energy expenditure and thermogenesis.

While creatine is known for muscle performance, it also supports metabolic heat generation in fat tissue. Maintaining adequate creatine levels may support metabolic health, though direct supplementation effects on human thermogenesis are not fully detailed here.

Leptin directly stimulates lipid oxidation and lipolysis in white adipose tissue (WAT) through sympathetic nervous system activation and direct receptor binding, independent of its central effects on food intake.

Leptin does directly tell fat cells to burn fat, but this happens mostly in the brain's control of appetite. The direct effect on fat cells requires very high hormone levels not seen in normal human physiology.

Chronic treatment with the beta-3 adrenergic receptor agonist mirabegron (50 mg/day) improves glucose homeostasis, insulin sensitivity, and pancreatic beta-cell function in obese, insulin-resistant humans without causing weight loss or brown adipose tissue activation.

For obese, insulin-resistant individuals, taking 50 mg of mirabegron daily for 12 weeks can significantly improve how the body processes glucose and insulin sensitivity, even without weight loss or the presence of brown fat. This suggests that targeting specific fat tissue receptors can improve metabolic health independently of weight change.

Fasting-induced hypoglycemia triggers tanycytes to upregulate VEGF-A, which increases fenestration of hypothalamic blood vessels and reorganizes tanycytic tight junctions to allow direct access of circulating metabolic hormones (e.g., leptin, ghrelin) to appetite-regulating neurons.

Your brain has a dynamic system that monitors your energy status. When you fast or have low blood sugar, your brain cells (tanycytes) temporarily open the 'windows' to your hypothalamus, allowing hunger and satiety hormones (like leptin and ghrelin) to directly signal your brain to adjust your appetite. This is a natural, adaptive response to ensure you eat when energy is low.

Insulin manipulation (restriction) to control weight in Type 1 Diabetes leads to chronic hyperglycemia, increased morbidity, and a threefold increase in relative risk of death.

If you have Type 1 Diabetes, never restrict your insulin to lose weight. This practice, known as 'diabulimia,' causes severe health complications and triples your risk of death. If you are struggling with body image or weight, seek help from a mental health professional or a diabetes specialist who can help you manage your weight safely without compromising your blood sugar.

Chronic activation of c-Jun N-terminal kinase (JNK) by elevated free fatty acids and pro-inflammatory cytokines during obesity causes insulin resistance and beta-cell dysfunction, leading to type 2 diabetes.

Obesity triggers a specific inflammatory response (JNK activation) that blocks insulin action. Managing obesity to reduce free fatty acids and inflammation is critical to preventing this molecular blockage.

Obese gut microbiota reduces the capacity to metabolize ethanolamine, leading to its accumulation in the gut, which triggers a molecular cascade (ARID3a/miR-101a-3p/Zo1) that weakens intestinal barriers, causing leaky gut, systemic inflammation, and glucose metabolic dysfunction.

If you are obese or have type 2 diabetes, your gut microbiome may be failing to break down ethanolamine, leading to gut leakiness and inflammation. Supporting your gut with probiotics that specifically metabolize ethanolamine may help restore gut barrier function and improve metabolic health. Focus on dietary patterns that support a diverse microbiome.

Adipose tissue-specific deletion of AMPK alpha subunits impairs cold-induced thermogenesis and mitochondrial biogenesis in inguinal white adipose tissue, leading to cold intolerance and exacerbated obesity on a high-fat diet.

This finding underscores the importance of maintaining healthy metabolic signaling in fat cells. While you cannot delete your AMPK genes, regular physical activity is known to activate AMPK, potentially supporting the browning of fat and metabolic health.

Endothelial cell CD36 acts as a gatekeeper for tissue fatty acid uptake; its deletion reduces lipid accumulation in heart and muscle, which shifts tissue metabolism toward glucose utilization and improves systemic insulin sensitivity.

This research suggests that how your body transports fat (specifically via endothelial CD36) influences your insulin sensitivity. While you cannot directly 'dose' this gene, the findings imply that strategies which reduce excessive lipid accumulation in muscle (lipotoxicity) may improve insulin sensitivity. This supports the concept that metabolic health is heavily dependent on tissue fuel selection (fat vs. glucose) rather than just caloric intake.

Gut-derived lipopolysaccharides (LPS) translocate across a dysfunctional intestinal barrier into the portal circulation, where they activate the TLR4 signaling pathway in liver cells, driving inflammation and fibrosis in NAFLD and ALD.

For individuals with fatty liver disease, the health of the gut barrier is directly linked to liver inflammation. Maintaining gut integrity through a balanced diet (like the Mediterranean diet) and potentially using targeted therapies (like probiotics or IAP) may help reduce liver damage by preventing harmful bacterial products (LPS) from entering the bloodstream and triggering liver inflammation.

Obesity-induced hypogonadism reduces testosterone and FSH levels, disrupting the blood-testis barrier and spermatogenesis.

Obesity alters your reproductive hormones by converting testosterone to estrogen, which lowers the testosterone needed for sperm production. Weight loss can help restore these hormone levels.

Obesity induces chronic inflammation and oxidative stress in the reproductive tract, damaging sperm DNA and membrane lipids.

Fat tissue releases inflammatory chemicals that damage sperm DNA and membranes. Weight loss reduces this inflammation, protecting sperm integrity.

Obesity-induced dysfunction of white adipose tissue (WAT) lipid sequestration capacity drives systemic insulin resistance by allowing toxic lipid accumulation in the liver and skeletal muscle, thereby increasing hepatic glucose output and impairing peripheral glucose disposal.

In obesity, the failure of fat cells to store fat safely leads to fat spilling into the liver and muscles, causing insulin resistance. Restoring the ability of adipose tissue to sequester lipids (e.g., through weight loss or specific metabolic therapies) is critical for resolving systemic insulin resistance, not just treating the liver or muscle directly.

Downregulation of specific adipokines (e.g., adiponectin, Neuregulin 4) and batokines (e.g., 12-HEPE, 12,13-diHOME) in obesity contributes to systemic insulin resistance by failing to suppress hepatic lipogenesis and promote peripheral glucose uptake.

Maintaining healthy adipose tissue function involves not just storage capacity but also the secretion of beneficial hormones. Obesity suppresses these protective factors (like Nrg4 and adiponectin), worsening insulin resistance. Weight loss and exercise can help restore these beneficial secretions.

Exercise-induced circadian phase shifts are not significantly different between young adults (18-30 years) and older adults (59-75 years), nor between men and women.

You do not need to adjust your exercise timing strategy based on your age or sex to achieve circadian phase shifts. The same timing principles apply to older adults as they do to younger adults.

Activation of the bile acid receptor TGR5 induces beige remodelling of white adipose tissue (scWAT) by promoting mitochondrial biogenesis and fission, thereby increasing energy expenditure and reducing adiposity.

This research identifies TGR5, a receptor activated by bile acids, as a key driver of fat-burning (beiging) in subcutaneous fat. While this is currently a pharmacological target (using mimetics like INT-777) in research, it suggests that dietary strategies influencing bile acid profiles or TGR5 activation could theoretically support metabolic health and fat loss by turning white fat into energy-expending beige fat.

Abnormalities in the enzymatic processing of the pro-opiomelanocortin (POMC) precursor in hypothalamic neurons critically disrupt the regulation of appetite, energy homeostasis, and body composition.

Understanding weight regulation requires looking beyond simple gene presence. If you have a genetic predisposition to obesity, it may not be just about 'having the gene' but about how your body processes hormones like POMC into active forms like alpha-MSH. This suggests that treatments targeting the processing enzymes (like PC2) or the hormone receptors themselves may be necessary for those with specific processing defects, rather than just focusing on caloric intake.

Obesity induces selective sympathetic nervous system (SNS) overactivity, particularly directed to muscle vasculature and kidneys, which contributes to cardiovascular risk (hypertension) but fails to increase energy expenditure or promote weight loss.

Understanding that obesity involves a specific type of nervous system stress (selective SNS activation) helps reframe the condition as a physiological state rather than just a willpower issue. While this state increases cardiovascular risk, it does not actively burn fat. Treatments targeting autonomic dysfunction (like weight loss itself) may reverse these alterations.

Selective leptin resistance in obesity preserves the sympathoexcitatory effects of leptin (increasing blood pressure) while blunting its appetite-suppressing effects.

In obesity, the body may become resistant to leptin's ability to tell you to stop eating, but it remains sensitive to leptin's ability to raise blood pressure. This explains why obese individuals often have high blood pressure even if they don't feel hungry.